NCT00677144 Oxaliplatin and S-1 (OS) Versus Oxaliplatin and Capecitabine (XELOX) for Advanced Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00677079 Single Arm Study of BSI-201 in Patients With BRCA-1 or BRCA-2 Associated Advanced Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT00675597 Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer Status COMPLETED Phase NA
NCT00674206 A Phase II Trial of Gemcitabine and Oxaliplatin for Triple Negative Metastatic Breast Cancer Status TERMINATED Phase PHASE2
NCT00670566 Irbesartan/Hydrochlorothiazide to Control Elevated Blood Pressure to Target in Moderate to Severe Hypertensive Patients Status COMPLETED Phase PHASE4
NCT00670228 Effect of Lantus and Apidra in Patients With Acute ST Elevation Myocardial Infarction Status TERMINATED Phase PHASE3
NCT00669370 Biweekly Docetaxel in Combination With Capecitabine as First-Line Treatment in Patients With Advanced Gastric Cancer Status UNKNOWN Phase PHASE2
NCT00669058 Dermatological Evaluation of Topic Compatibility-Dermacyd Tina Gel Tangerina Mix Status COMPLETED Phase PHASE3
NCT00668668 Dermatological Evaluation of Topic Compatibility-Dermacyd Tina Gel Sweet Flower Status COMPLETED Phase PHASE3
NCT00668577 Dermatological Evaluation of Topic Compatibility - Dermacyd Breeze Status COMPLETED Phase PHASE3
NCT00668460 Dermatological Evaluation of Topic Compatibility-Dermacyd Delicata Pocket BR Status COMPLETED Phase PHASE3
NCT00664417 Study of Different Formulations of an Intramuscular A/H5N1 Inactivated, Split Virion Influenza Adjuvanted Vaccine Status COMPLETED Phase PHASE1
NCT00664391 Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Breeze Status COMPLETED Phase PHASE3
NCT00664144 Rasburicase for the Treatment/Prevention of Hyperuricemia in Adult Patients With Relapsing Aggressive Non Hodgkin's Lymphoma Status TERMINATED Phase PHASE2
NCT00663390 Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Delicata Pocket BR Status COMPLETED Phase PHASE3